Clinical trial
Simvastatin Treatment of Patients With Acute Optic Neuritis
NCT00261326 · Glostrup University Hospital, Copenhagen, Other · Unknown status
Key facts
| NCT number | NCT00261326 |
|---|---|
| Title | Simvastatin Treatment of Patients With Acute Optic Neuritis |
| Official title | Simvastatin Treatment of Patients With Acut Optic Neuritis. A Doubleblind, Randomized and Placebo Controlled Fase III Trial |
| Lead sponsor | Glostrup University Hospital, Copenhagen, Other |
| Collaborators | Alpharma ApS Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Optic Neuritis, Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | simvastatin, placebo |
| Enrollment | 64 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | May 1, 2011 |
| First posted | Dec 5, 2005 |
| Last update posted | Jan 10, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: